93
Participants
Start Date
April 4, 2017
Primary Completion Date
November 2, 2017
Study Completion Date
November 2, 2017
Data collection
This is a non-interventional study, the decision to prescribe the product would have been taken prior to, and independently from the decision to enrol the patient.
National Transitional Research, East Setauket
Allegheny Cancer Center, Pittsburgh
Mercy Medical Center, Baltimore
Moffitt Cancer Center, Tampa
Mayo Clinic, Rochester
Cancer Center of Kansas, Wichita
Ochsner Clinic Foundation, New Orleans
Tufts Medical Center, Boston
Lead Sponsor
Ipsen
INDUSTRY